DERMESTRIL-Septem is a hormone replacement therapy (HRT). It contains 17-β-estradiol. DERMESTRIL-Septem is used in postmenopausal women whose last natural bleeding was at least 6 months ago.
DERMESTRIL-Septem is used for the following purposes:
Relief of symptoms that occur after menopause. During menopause, the amount of estrogen produced by a woman’s body decreases. This can lead to symptoms such as a feeling of warmth in the face, neck and chest (hot flashes).
DERMESTRIL-Septem relieves these symptoms after menopause. DERMESTRIL-Septem will only be prescribed if your symptoms significantly affect your daily life.
Compound:
DERMESTRIL-Septem patches contain the estrogenic hormone 17-ß-estradiol. The patches are attached to the skin after the protective film is removed, and the hormone continuously diffuses through the skin into the body. DERMESTRIL-Sentem 25 mcg/24 hours contains 2.5 mg estradiol (as hemihydrate) and releases approximately 25 mcg of estradiol per day (over 24 hours). Other components are adhesives (acrylic copolymers), carrier film (polyethylene terephthalate) and protective film (siliconized polyethylene terephthalate) which is removed before use. DERMESTRIL-Septem patches are intended for external use only.
